Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Cancer

• Publication date

  2006-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22269PMID 16998791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Cancer Statistics, 2002

  2005cited by this paper
• Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast‐ovarian cancer families

  2004influential reference
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2004cited by this paper
• Karachi Cancer Registry Data--implications for the National Cancer Control Program of Pakistan.

  2004influential reference
• Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India

  2004cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2003cited by this paper
• Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins

  2002cited by this paper
• Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.

  2002cited by this paper
• The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

  2002cited by this paper
• Variation in BRCA1 cancer risks by mutation position.

  2002cited by this paper
• Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

  2002cited by this paper
• Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany

  2002cited by this paper
• Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2

  2002cited by this paper
• Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.

  2001cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

  2001cited by this paper
• Cancer incidence in Karachi, Pakistan: First results from Karachi Cancer Registry

  2000cited by this paper
• Identification of specific BRCA1 and BRCA2 variants by DHPLC.

  2000cited by this paper
• Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients

  1999cited by this paper
• A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

  1999cited by this paper
• The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

  1998cited by this paper
• Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions

  1998influential reference
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.

  1998cited by this paper
• Is carcinoma breast a different disease in Pakistani population?

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• German family study on hereditary breast and/or ovarian cancer: Germline mutation analysis of the BRCA1 gene

  1997cited by this paper
• Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

  1997cited by this paper
• Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.

  1996cited by this paper
• Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.

  1996cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996cited by this paper
• Breast carcinoma in Pakistani women.

  1996cited by this paper
• Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.

  1995cited by this paper
• An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Cancer Incidence in Five Continents

  1970cited by this paper

• Application of a targeted panel to search for genetic variants of hereditary breast cancer

  2026cites this paper
• Predicting the likelihood of carrying BRCA1 or BRCA2 pathogenic variants in high-risk Pakistani breast cancer patients

  2025cites this paper
• Genetic landscape of Pakistani familial breast cancer patients using multigene panel testing

  2025cites this paper
• Prevalence of Novel and Recurrent Pathogenic Variants in BRCA Genes in a Cohort of Iranian Hereditary Breast Cancer Patients

  2025cites this paper
• Anticipation effect in Pakistani breast cancer families with or without BRCA1/2 pathogenic variants.

  2025cites this paper
• ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY.

  2025cites this paper
• Association of Genetic Risk Variants in SETBP1, FANCM, and LSP1 with Familial Breast Cancer in the Pakistani Pashtun Population

  2025cites this paper
• Spectrum of BRCA1/2 Pathogenic Variants in Southern and Western Asia-A Systematic Review.

  2025cites this paper
• Next generation sequencing analysis of BRCA1/2 genes reveals clinically significant pathogenic mutations in ovarian cancer patients

  2024cites this paper
• Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from Yunnan Province in southwest China

  2024cites this paper
• BRCA1/2 mutations in GI cancers: the risk to Pakistani families

  2023cites this paper
• Medical students' self‐perceived knowledge and clinical comfort with genetics in Pakistan

  2023cites this paper
• Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan

  2023influential citation
• Correlation of p53 Expression with Grade and Stage of Ovarian Surface Epithelial Cancer

  2023cites this paper
• Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan

  2023cites this paper
• Pakistani healthcare professionals’ perceptions of communication with patients and their relatives about hereditary breast cancer: a qualitative study in a LMIC

  2023cites this paper
• Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan.

  2022cites this paper
• BREAST CANCER IN PAKISTAN-AN UPDATED OVERVIEW

  2022cites this paper
• BRCA1/BRCA2 mutation spectrum analysis in South Asia: a systematic review

  2022cites this paper
• Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan

  2022cites this paper
• Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan

  2022cites this paper
• Exploring genetic variants of BRCA1 and BRCA2 in Indian Breast Cancer cases

  2022cites this paper
• Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients

  2022cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• Fluorometric determination of the breast cancer 1 gene based on the target-induced conformational change of a DNA template for copper nanoclusters.

  2021cites this paper
• Germline Mutation Analysis in Sporadic Breast Cancer Cases With Clinical Correlations

  2021cites this paper
• Quality of Life in Ovarian Cancer: A Threat to Women Health in Pakistan

  2021cites this paper
• Case study: A qualitative study aimed at comparing standard therapy in a breast cancer patient to the spiritual healing and psychological support, in improving patient’s compliance

  2021cites this paper
• ASSOCIATION BETWEEN BRCA1 POLYMORPHISMS AND BREAST CANCER IN SAARC COUNTRIES

  2021cites this paper
• Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan

  2021cites this paper
• Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer

  2021cites this paper
• Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients

  2020cites this paper
• The potential role of dietary plant ingredients against mammary cancer: a comprehensive review

  2020influential citation
• Electrochemical DNA Sensor for Sensitive BRCA1 Detection Based on DNA Tetrahedral-Structured Probe and Poly-Adenine Mediated Gold Nanoparticles

  2020cites this paper
• Knowledge, attitude, and practice of breast self-examination among female undergraduate medical students in Poonch Medical College, Azad Kashmir.

  2020cites this paper
• GENETIC VARIATIONS OF BREAST CANCER PATIENTS IN PAKISTAN

  2020cites this paper
• PREVALENCE OF BRCA1/BRCA2 MUTATIONS IN THE PAKISTANI BREAST CANCER PATIENTS

  2020cites this paper
• A Flexible DNA Biosensor for Breast Cancer Marker BRCA1 Detection

  2020cites this paper
• Gene Panel Sequencing in a Chinese High-risk Breast Cancer Cohort

  2019cites this paper
• Screening, diagnosis and genetic study of breast cancer patients in Pakistan

  2019cites this paper
• Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study

  2019cites this paper
• Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

  2018influential citation
• Accuracy of Triple Assessment in Diagnosis of Breast Cancer in Women More than 40 Years of Age

  2018cites this paper
• Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols

  2018influential citation
• Association of BRCA1 185 del AG with early age onset of breast cancer patients in selected cohort from Pakistani population

  2018cites this paper
• A MOLECULAR-BASED APPROACH TO INVESTIGATE BREAST CANCER 1 AND BREAST CANCER 2 STATUS IN OVARIAN CANCER AMONG IRAQI WOMEN

  2018cites this paper
• INHERITED GENETIC SUSCEPTIBILITY TO BREAST CANCER IN PAKISTAN

  2018influential citation
• Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls

  2018cites this paper
• Germ-Line Mutanome Profiling of The Breast Cancers in Pakistani Population

  2018cites this paper
• The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

  2017cites this paper
• Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms

  2017cites this paper
• Genetic Mutations Associated with Breast Cancer in Pakistan

  2017cites this paper
• Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.

  2017cites this paper
• Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

  2016cites this paper
• High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients

  2016cites this paper
• Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer

  2016cites this paper
• Genomic approach to understand association between single nucleotide polymorphisms and risk of Korean serous ovarian cancer at stage IIIc

  2016cites this paper
• A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome

  2016cites this paper
• Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

  2016cites this paper
• Screening for Del 185 AG and 4627C>A BRCA1 Mutations in Breast Cancer Patients from Lahore, Pakistan.

  2016cites this paper
• A Pilot Study on Screening of BRCA1 Mutations (185delAG, 1294del40) in Nepalese Breast Cancer Patients.

  2016cites this paper
• RELATIONSHIP OF EMOTIONAL INTELLIGENCE AND HEALTH LOCUS OF CONTROL AMONG FEMALE BREAST CANCER PATIENTS IN PAKISTAN

  2016cites this paper
• Potential Risk Factors for Breast Cancer in Pakistani Women.

  2016influential citation
• Cancer patterns in Karachi (all districts), Pakistan: First results (2010-2015) from a Pathology based cancer registry of the largest government-run diagnostic and reference center of Karachi.

  2016cites this paper
• Vitamin D Receptor Cdx-2 Polymorphism and Premenopausal Breast Cancer Risk in Southern Pakistani Patients

  2015cites this paper
• Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations

  2015cites this paper
• Discussing Genetic Testing With Patients With Breast Cancer in Developing Countries: Should We Be Judicious?

  2015cites this paper
• BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

  2015cites this paper
• The role of self-help group in Jordan following treatment for breast cancer

  2015cites this paper
• Low fouling label-free DNA sensor based on polyethylene glycols decorated with gold nanoparticles for the detection of breast cancer biomarkers.

  2015cites this paper
• Absence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan

  2015cites this paper
• Carcinogenic Factors of Breast Cancer in Female of Pakistan

  2015cites this paper
• Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study

  2015influential citation
• Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries

  2015cites this paper
• Nanosheet Au/Co3O4-based ultrasensitive nonenzymatic immunosensor for melanoma adhesion molecule antigen.

  2014cites this paper
• Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.

  2014cites this paper
• Prevalence, risk factors and disease knowledge of breast cancer in Pakistan.

  2014cites this paper
• Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan

  2014cites this paper
• Completeness of pedigree and family cancer history for ovarian cancer patients

  2014cites this paper
• Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population.

  2013influential citation
• Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer

  2013cites this paper
• Construction of label-free electrochemical immunosensor on mesoporous carbon nanospheres for breast cancer susceptibility gene.

  2013cites this paper
• Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan

  2013influential citation
• Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases.

  2013cites this paper
• Managing the illness experience of women with advanced breast cancer: hopes and fears of cancer-related insecurity.

  2013cites this paper
• GENETIC COUNSELING: A GLOBAL PERSPECTIVE The Views of Pakistani Doctors Regarding Genetic Counseling Services – Is there a Future?

  2013influential citation
• A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer

  2013cites this paper
• Frequency of Pro Allele on Codon 72 of TP53 in Female Breast Cancer Patients of Pakistan: Molecular Stress or Geography

  2013cites this paper
• Mutational Spectrum of Gelsolin and Its Down Regulation Is Associated with Breast Cancer

  2013cites this paper
• Cancer of the Breast and Female Reproductive Tract

  2013cites this paper
• The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study

  2012cites this paper
• Histomorphological Spectrum of Ovarian Tumors with Immunohistochemical Analysis of Poorly or Undifferentiated Malignancies

  2012cites this paper
• Personalized Medicine for Cancer in the Developing World

  2012cites this paper
• Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer

  2012cites this paper
• Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

  2012cites this paper
• Role of cancer awareness in prevention of its outbreak : current scenario in Pakistan

  2012cites this paper
• Race and the Molecular Origins of Breast Cancer in Chinese Women

  2012cites this paper
• Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients

  2012cites this paper